COVID-19: Are men the weaker sex?

Along with Italian colleagues, Prof Robert Millar published a paper in the journal Neuroendocrinology about the differences between men and women in terms of COVID-19 outcomes, focusing on the role that sex hormones play on the severity and outcome of the infection and the complex interplay of sex with the ACE2 and TMPRSS2 enzymes, and inflammatory and immune systems.

Angiotensin-converting enzyme 2 (ACE2) is attached to the membranes of cells in the lungs, arteries, heart, kidneys and intestines; transmembrane protease serine 2 (TMPRSS2) is an enzyme that is encoded in humans by the TMPRSS2 gene, and plays a crucial role when the virus enters the cells. Prof Millar expands on this further.

What are the differences between men and women in terms of COVID-19 outcomes?

A study by a team of scientists at the Max Delbrück Center for Molecular Medicine (MDC) in Berlin, Germany and the University of Pretoria (UP) has found that naked mole-rats can communicate with one another within their own colony. They do this with a unique dialect that is specific to that individual colony.

Previous Next

There are substantial sexual disparities between the outcome of COVID-19 disease in men and women. Numerous studies have confirmed that while there is no difference in the proportion of males and females with confirmed COVID-19, male patients have almost three times the odds of requiring admission for intensive treatment and higher odds of death compared to females. These are global figures, but even in Africa, where data is sparser, there are almost twice as many COVID-19 deaths in men compared to women.

What is the mechanism underlying this sexual disparity?

It involves the immune system, which has several players, as well as the inflammatory system. There are two bottom lines: the way the virus gets into cells, and the way it promotes itself to produce a viral load through two molecules. One of these molecules is ACE2, a protein that the virus uses to get into cells. The spike proteins on the virus have an amino acid sequence that interacts through cognate amino acid sequences, mediating attachment to ACE2. The attachment of the virus through its spike protein needs a protease (TMPRSS2) to cleave the spike protein; together, they facilitate the entry of the virus into cells where they direct the cell machinery to make more of the virus. There is also evidence that TMPRSS2 cleaves the amino terminus of ACE2 in the interaction for viral entry. It appears that both are needed.

The expression of these two critical proteins differs in men and women. The ACE2 is expressed in high levels in the lungs, blood vessels and gastrointestinal tract of men. But in women, ACE2 is expressed predominantly in the pancreas and adipose tissue. Therefore, in men, ACE2 is expressed in tissue, which allows the entry of the virus into the respiratory system. Together with the suppressive effects of androgen on the immune system and the complex interplay of inflammatory and immune proteins, this puts men at greater risk of morbidity and mortality.

Importantly, androgen binds androgen receptors in viral entry cells, which then bond to androgen-response elements in the ACE2 and TMPRSS2 genes to increase protein expression. Oestrogen appears to do the opposite, thus protecting women from high levels of viral entry.

Does age influence the severity of COVID-19?

The outcomes are far worse in older people than in younger people. However, the sexual difference between men and women remains the same, even in older people. The death rate is a good end point as a measure. Whether it is a younger group or an older group, the death rate for men from COVID-19 is generally twice as high as for women, even in the older group. Of course, there are exceptions: postmenopausal women have worse outcomes, but those on oestrogen-replacement appear to have better outcomes.

What was the finding regarding a new therapeutic approach?

We concluded: why not give oestrogen patches to men as an acute treatment (short term)? The other approach would be to take away androgen by using androgen antagonists or inhibitors that stop the production of testosterone. Interestingly, there is already evidence that men on anti-androgen treatment – for prostate cancer, for example – have lower morbidity and mortality. Since treatment with oestrogen or androgen antagonists would use well-known drugs that have already been approved for other purposes, trials of this nature would be straight forward to do as acute studies.

Researchers

• Lorem ipsum

  Lorem ipsum dolor sit amet, consectetur adipiscing elit. Mauris efficitur, turpis eget efficitur maximus, augue odio sagittis lectus, ultricies euismod est ligula ac ligula. Vestibulum ac enim felis. Morbi lobortis congue efficitur. In hac habitasse platea dictumst. Sed malesuada, erat ac iaculis interdum, arcu augue mattis turpis, vel hendrerit sapien urna vel tortor. Proin imperdiet sem id rutrum scelerisque.

  More from this Researcher
• 

  Prof Michael S Pepper

  Director, Institute for Cellular and Molecular Medicine and Director, South African Medical Research Council {SAMRC) Extramural Unit for Stem Cell Research and Therapy Department of Immunology, Faculty of Health Sciences Area of research: Translational multi-disciplinary cellular and molecular medicine Professor Michael Pepper has been doing research at UP since 2005. Hy says his research is aimed at improving the quality of life of South Africans and reducing the heavy disease burden in the country. His group’s research goal is to understand disease pathogenesis and to develop cell and gene therapies for selected diseases. His research group has identified key areas that contribute to the burden of disease in South Africa including communicable disease such as HIV and Covid-19, non-communicable diseases including obesity or cancer, and maternal and child health issues such as “birth asphyxia”. The project on “birth asphyxia” has recently received funding from the Bill and Melinda Gates Foundation and Professor Pepper’s research group is working on the identification of biomarkers (molecular and imaging) for this condition. This is important for understanding disease pathogenesis as well as for the design of an interventional clinical trial aimed at assessing the efficacy of one or more neuroprotective agents in these patients. In the past 18 months Professor Pepper’s research group has started two new Covid-19 projects namely genetic determinants of susceptibility and severity as well as novel therapies for acute respiratory distress syndrome (ARDS). Professor Pepper is working with Professor Fourie Joubert from the Faculty of Natural and Agricultural Sciences and Professor Pieter de Villiers from the Faculty of Engineering, Built Environment, and Information Technology in trenadisciplinary cross-faculty research. Professor Pepper says the work they are doing is inspired by a need to address the needs of the country, and to ensure that taxpayers’ money is being spent responsibly. Significant advances are being made, and medical research in selected fields in South Africa is being conducted at the highest level globally. Professor Pepper’s advice to prospective and undergraduate students who are interested in his field is to find their passion and not to be driven by a desire for fame or material goods. They should be prepared to work hard and be ready to adapt to the rapidly changing environment in which we live. His hobbies and interests are horse-riding and theatre. (Words 388)

  More from this Researcher
• 

  Prof Lise Korsten

  Prof Korsten is currently the Co-Director within the Department of Science and Technology, Centre of Excellence Food Security. She is also responsible for the food safety and regulatory control programmes within the DST Centre of Excellence Food Security. She is a chief editor of Crop Protection and is chairing the International Society for Plant Pathology Task Force on Global Food Security.

  More from this Researcher

Related Lecture

• 

  Human rights in a time of homophobia: An argument for equal legal protection of 'sexual minorities' in Africa.

Related Infographics

• 

  Men vs women in the battle against COVID-19

• 

  Men vs women in the battle against COVID-19

• 

  City